|
1
|
Quinones A and Saric M: The cholesterol
emboli syndrome in atherosclerosis. Curr Atheroscler Rep.
15:315–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saric M and Kronzon I: Aortic
atherosclerosis and embolic events. Curr Cardiol Rep. 14:342–349.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scolari F and Ravani P: Atheroembolic
renal disease. Lancet. 375:1650–1660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thériault J, Agharazzi M, Dumont M,
Pichette V, Ouimet D and Leblanc M: Atheroembolic renal failure
requiring dialysis: Potential for renal recovery? A review of 43
cases. Nephron Clin Pract. 94:c11–c18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meyrier A: Cholesterol crystal embolism:
Diagnosis and treatment. Kidney Int. 69:1308–1312. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minota S: ANCA in atheroembolism; just a
coincidence or bearing cause and effect? Intern Med. 45:495–496.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schönermarck U, Csernok E and Gross WL:
Pathogenesis of anti-neutrophil cytoplasmic antibody-associated
vasculitis: Challenges and solutions 2014. Nephrol Dial Transplant.
30(Suppl 1): i46–i52. 2015.PubMed/NCBI
|
|
8
|
Scolari F, Tardanico R, Zani R, Pola A,
Viola BF, Movilli E and Maiorca R: Cholesterol crystal embolism: A
recognizable cause of renal disease. Am J Kidney Dis. 36:1089–1109.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aviles B, Ubeda I, Blanco J and Barrientos
A: Pauci-immune extracapillary glomerulonephritis and atheromatous
embolization. Am J Kidney Dis. 40:847–851. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De RS, Serratrice J, Granel B, Disdier P,
Bartoli JM, Pache X, Astoul P, Garbe L, Branchereau A and Weiller
PJ: Periaortitis heralding Wegener's granulomatosis. J Rheumatol.
29:392–394. 2002.PubMed/NCBI
|
|
11
|
Delen S, Boonen A, Landewé R, Kroon AA,
van der Linden S and Tervaert JW: An unusual case of ANCA positive
disease. Ann Rheum Dis. 62:780–781. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kaplan-Pavlovcic S, Vizjak A, Vene N and
Ferluga D: Antineutrophil cytoplasmic autoantibodies in
atheroembolic disease. Nephrol Dial Transplant. 13:985–987. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maejima H, Noguchi T and Tanei R:
Cholesterol embolism associated with MPO-ANCA. Eur J Dermatol.
20:539–540. 2010.PubMed/NCBI
|
|
14
|
Maeshima E, Yamada Y, Mune M and Yukawa S:
A case of cholesterol embolism with ANCA treated with
corticosteroid and cyclophosphamide. Ann Rheum Dis. 60:7262001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miguélez A, Barrientos N, López-Rios F,
Vanaclocha F and Iglesias L: Necrotic livedo reticularis, multiple
cholesterol emboli and ANCA. J Eur Acad Dermatol Venereol.
17:351–352. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palmgren E, Hartford M and Herlitz H:
Cholesterol embolism-a serious systemic disease. Lakartidningen.
97:1263–1266. 2000.(In Swedish). PubMed/NCBI
|
|
17
|
Peat DS and Mathieson PW: Cholesterol
emboli may mimic systemic vasculitis. BMJ. 313:546–547. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugimoto T, Morita Y, Yokomaku Y, Isshiki
K, Kanasaki K, Eguchi Y, Koya D and Kashiwagi A: Systemic
cholesterol embolization syndrome associated with
myeloperoxidase-anti-neutrophil cytoplasmic antibody. Intern Med.
45:557–561. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scolari F, Ravani P, Gaggi R, Santostefano
M, Rollino C, Stabellini N, Colla L, Viola BF, Maiorca P,
Venturelli C, et al: The challenge of diagnosing atheroembolic
renal disease: Clinical features and prognostic factors.
Circulation. 116:298–304. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ravani P, Gaggi R, Rollino C, Santostefano
M, Stabellini N, Colla L, Dallera N, Ravera S, Bove S, Faggiano P
and Scolari F: Lack of association between dialysis modality and
outcomes in atheroembolic renal disease. Clin J Am Soc Nephrol.
5:454–459. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kallenberg CG: Pathogenesis and treatment
of ANCA-associated vasculitides. Clin Exp Rheumatol. 33(4 Suppl
92): S11–S14. 2015.PubMed/NCBI
|
|
22
|
van Haelst PL, Asselbergs FW, van Doormaal
JJ, Veeger NJ, May JF, Holvoet P, Gans RO and Tervaert JW:
Antineutrophil cytoplasmatic antibodies in patients with premature
atherosclerosis: Prevalence and association with risk factors. J
Intern Med. 251:29–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Lind van Wijngaarden RA, van Rijn L,
Hagen EC, Watts RA, Gregorini G, Tervaert JW, Mahr AD, Niles JL, de
Heer E, Bruijn JA and Bajema IM: Hypotheses on the etiology of
antineutrophil cytoplasmic autoantibody associated vasculitis: The
cause is hidden, but the result is known. Clin J Am Soc Nephrol.
3:237–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ntatsaki E, Carruthers D, Chakravarty K,
D'Cruz D, Harper L, Jayne D, Luqmani R, Mills J, Mooney J, Venning
M, et al: BSR and BHPR guideline for the management of adults with
ANCA-associated vasculitis. Rheumatology (Oxford). 53:2306–2309.
2014. View Article : Google Scholar : PubMed/NCBI
|
